slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
166,381-166,440 of 319,975
46
The slide uses a timeline framework to map out specific diversity KPIs and recruitment process changes.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
47
The slide uses a timeline framework to map current initiatives against future goals.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
48
The slide uses a timeline framework to map out strategic initiatives leading to a 2030 KPI.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
49
Asos | Investor Day Presentation Deck | 56 slidesAsos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
50
The slide uses a vertical color-coded gradient bar on the left to indicate progress or sectioning.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
51
Asos | Investor Day Presentation Deck | 56 slidesAsos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
52
The slide uses a hierarchical organizational chart to illustrate reporting lines from working groups up to the PLC Board.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
53
Slide 53 of a presentation. Features logos of CDP, TCFD, MSCI, and Sustainalytics.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
54
Asos | Investor Day Presentation Deck | 56 slidesAsos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
55
The slide uses a simple 2-column layout to categorize ESG goals.Asos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
56
Asos | Investor Day Presentation Deck | 56 slidesAsos | Investor Day Presentation Deck | 56 slides · ASOS
Conference presentation Investor relations Beat · Solution1 hit
01
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
03
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
04
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
05
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
06
The diagram uses a circular flow representing different therapeutic modalities (Immune engagers, Cell therapy, Oncolytic virus, Immuno-oncology, DNA damage response, Antibody drug conjugates, Radioimmuno-conjugates, Nanomedicines, Epigenetics).AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Includes a timeline of 5 years of Presidential Symposia/Presentations.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide features a stylized silhouette of a person with a molecular/cellular visualization in the chest area.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
Clinical trial design diagram showing randomization between T-DXd and T-DM1.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
10
Standard clinical trial patient flow diagram.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
11
Waterfall plots show best percentage change in sum of diameters from baseline for two treatment arms.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
12
Kaplan-Meier survival analysis plot with a risk table below.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
13
Kaplan-Meier survival analysis plot with a risk table at the bottom.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
14
Clinical trial data presentation; includes 'Patients Still at Risk' table and statistical summary.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
15
The table compares safety profiles of two drugs across various adverse event categories.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
Includes footnotes regarding patient exclusions and definitions of LVEF events.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
The slide highlights PFS, ORR, OS, and safety profile metrics.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a timeline-like arrow structure to represent lines of therapy (1L, 2L, 3L+).AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
19
The slide features a stylized silhouette of a person with a molecular/antibody illustration inside the chest area.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
20
The slide uses a chronological progression (Today, 2022, Future) to frame the drug's market expansion.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
21
The slide uses a matrix-like layout to map disease states (rows) against treatment lines (columns).AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
The slide features a stylized silhouette of a person with a molecular/antibody structure overlaid on the chest area.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
23
Slide presents two distinct clinical trial visualizations: a Kaplan-Meier survival curve and a waterfall plot.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
24
The slide uses a color-coded system to distinguish between monotherapy (purple) and combination therapy (yellow) clinical trials.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
25
The slide presents two distinct clinical data sets: a table for PACIFIC-R and a Kaplan-Meier survival curve for the COAST trial.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
26
Slide displays multiple clinical trial results (Kaplan-Meier curves and waterfall plots) across different drug combinations.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
27
The slide features a stylized silhouette of a human head and torso with biological/molecular imagery inside.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
The slide uses a process flow diagram to map eligibility criteria to specific patient cohorts.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
The slide uses a process flow diagram to illustrate the trial structure.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
Clinical trial design diagram showing patient flow from enrollment to treatment arms.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
Includes a table of clinical outcomes (PFS-10 months, ORR) and a risk table at the bottom.AstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
AstraZeneca | Investor Day Presentation Deck | 34 slidesAstraZeneca | Investor Day Presentation Deck | 34 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Azek | Investor Presentation Deck | 37 slidesAzek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What Is1 hit
02
Azek | Investor Presentation Deck | 37 slidesAzek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What Is1 hit
03
The slide uses a split-layout with a blue sidebar for corporate identity and a large lifestyle image on the right.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What Is1 hit
04
The slide serves as a brand and product catalog overview.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What Could Be1 hit
05
The slide uses a structured layout to present four strategic pillars alongside a right-hand column of key performance indicators.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What Could Be1 hit
06
Mixed dashboard slide combining bar charts, KPI callouts, photo, and bullet list to summarize financial performance and competitive positioning.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What Could Be1 hit
07
The slide uses a combination of market sizing and qualitative drivers (architect popularity, replacement cycle) to justify the growth thesis.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
08
Uses a before-and-after visual comparison for product value proposition.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
09
The slide uses a 2x2 grid layout to showcase four distinct product categories/technologies.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
10
Includes a central flywheel diagram representing core values.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · New Bliss1 hit
11
The slide uses a layered chevron-based diagram to represent the business model.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · New Bliss1 hit
12
The growth equation is presented as a waterfall-style diagram.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations Beat · New Bliss1 hit
13
The slide uses a waterfall-style diagram to show margin drivers and a circular process diagram for the AIMS framework.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations 1 hit
14
Includes a visual representation of the product composition and a reference to a 2020 ESG report.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations 1 hit
15
Uses a before-after-bridge framing to show the transformation of waste into a premium product.Azek | Investor Presentation Deck | 37 slides · The AZEK Company
Pitch deck Investor relations 1 hit